PMC10448185_01
Clinical history of the patient and agency recommendations. PGx test, pharmacogenetics analysis; ADR, adverse drug reaction.
fphar-14-1237446-g001.jpg
PMC10448185_01_fphar-14-1237446-g001.jpg
F1
During admission, no data of psychotic decompensation were objectified, despite quetiapine at a dose of 50 mg/day being the only antipsychotic treatment, so the hypothesis of catatonia was discarded (Figure 1).